These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8550362)

  • 21. Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients.
    Rossi P; Lorenzo GD; Formisano R; Buzzi MG
    Headache; 2004; 44(7):713-8. PubMed ID: 15209695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sumatriptan--future development, alternative features and potential new indications].
    Arnold WS
    Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms.
    Hardebo JE
    Headache; 1993 Jan; 33(1):18-21. PubMed ID: 8382200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache.
    Dahlöf C; Ekbom K; Persson L
    Arch Neurol; 1994 Dec; 51(12):1256-61. PubMed ID: 7986182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
    Berges A; Walls C; Lener SE; McDonald SA
    Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group.
    Facchinetti F; Bonellie G; Kangasniemi P; Pascual J; Shuaib A
    Obstet Gynecol; 1995 Dec; 86(6):911-6. PubMed ID: 7501338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral zolmitriptan is effective in the acute treatment of cluster headache.
    Bahra A; Gawel MJ; Hardebo JE; Millson D; Breen SA; Goadsby PJ
    Neurology; 2000 May; 54(9):1832-9. PubMed ID: 10802793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 32. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months.
    Ekbom K; Waldenlind E; Cole J; Pilgrim A; Kirkham A
    Cephalalgia; 1992 Aug; 12(4):254-6. PubMed ID: 1326405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group.
    Ekbom K; Monstad I; Prusinski A; Cole JA; Pilgrim AJ; Noronha D
    Acta Neurol Scand; 1993 Jul; 88(1):63-9. PubMed ID: 8396833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sumatriptan nasal spray for the treatment of cluster headache].
    Watanabe M; Oda A
    No To Shinkei; 2005 Jan; 57(1):65-8. PubMed ID: 15782603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
    Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S
    Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in frequency pattern in cluster headache induced by subcutaneous sumatriptan.
    Gupta VK
    Headache; 2005 Sep; 45(8):1089-90. PubMed ID: 16109129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.